• 1. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 2. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 3. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 4. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 5. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Carboxylic acids

Introduction to 3-Chloroadamantane-1-carboxylic acid (CAS No. 34859-74-0)

3-Chloroadamantane-1-carboxylic acid, with the chemical formula C??H??ClCO?H, is a significant compound in the field of organic chemistry and pharmaceutical research. This molecule, characterized by its adamantane core substituted with a chlorine atom and a carboxylic acid group, has garnered considerable attention due to its unique structural properties and potential applications in medicinal chemistry. The presence of both the rigid adamantane skeleton and the reactive carboxylic acid moiety makes it a versatile intermediate for synthesizing more complex molecules, particularly in the development of novel therapeutic agents.

The adamantane framework, known for its exceptional stability and lipophilicity, provides a favorable scaffold for drug design. Its three-dimensional structure mimics certain biological cavities, making it an attractive candidate for binding interactions with biological targets. In contrast, the chloroadamantane derivative introduces a site for further functionalization, allowing chemists to tailor the molecule's properties for specific applications. The carboxylic acid group at the 1-position further enhances its utility as a precursor in peptide mimetics and protease inhibitors.

Recent advancements in pharmaceutical research have highlighted the potential of 3-Chloroadamantane-1-carboxylic acid in addressing various therapeutic challenges. One notable area of interest is its role in developing kinase inhibitors, which are critical in treating cancers and inflammatory diseases. The adamantane moiety's ability to interact deeply with protein pockets has been leveraged to design molecules with high selectivity and potency. For instance, studies have demonstrated that derivatives of 3-Chloroadamantane-1-carboxylic acid can serve as scaffolds for creating inhibitors targeting tyrosine kinases, which play a pivotal role in cell signaling pathways associated with diseases such as leukemia and rheumatoid arthritis.

Another emerging application of this compound is in the field of neurodegenerative disease research. Researchers have explored its potential as a precursor for molecules that can modulate acetylcholinesterase activity, which is relevant in conditions like Alzheimer's disease. The structural rigidity of the adamantane core helps stabilize the active site of enzymes, improving binding affinity. Additionally, the chlorine substituent can be further modified to introduce other functional groups that enhance bioavailability and metabolic stability.

The synthesis of 3-Chloroadamantane-1-carboxylic acid involves multi-step organic transformations that highlight its synthetic versatility. One common approach begins with the halogenation of adamantane derivatives followed by carboxylation at the 1-position. This process often employs palladium-catalyzed cross-coupling reactions to introduce the chlorine atom efficiently. The subsequent carboxylation step can be achieved through oxidation or direct carboxylation methods, depending on the desired purity and yield.

In terms of pharmacokinetic properties, 3-Chloroadamantane-1-carboxylic acid exhibits favorable solubility characteristics due to the presence of the carboxylic acid group, which aids in aqueous solubility while maintaining lipophilicity through the adamantane moiety. This balance is crucial for drug development, as it influences absorption, distribution, metabolism, and excretion (ADME) profiles. Furthermore, computational modeling studies have suggested that this compound can effectively penetrate blood-brain barriers, making it a promising candidate for central nervous system (CNS) drug delivery.

The compound's stability under various conditions has also been thoroughly investigated. Studies indicate that 3-Chloroadamantane-1-carboxylic acid maintains its structural integrity under moderate temperatures and pH conditions, which is essential for formulation stability in pharmaceutical products. However, its reactivity with nucleophiles necessitates careful handling during synthesis and purification to avoid unwanted side reactions.

Industrial-scale production of 3-Chloroadamantane-1-carboxylic acid has been optimized to meet pharmaceutical-grade standards. Advances in green chemistry have led to more sustainable synthetic routes that minimize waste generation and reduce reliance on hazardous reagents. These innovations not only improve cost-efficiency but also align with global efforts to promote environmentally responsible chemical manufacturing.

Future research directions may explore novel derivatives of 3-Chloroadamantane-1-carboxylic acid, particularly those designed for targeted drug delivery systems such as prodrugs or nanoparticles. The combination of its rigid structure with functionalizable sites offers endless possibilities for creating next-generation therapeutics that address unmet medical needs more effectively.

In conclusion,3-Chloroadamantane-1-carboxylic acid represents a valuable asset in modern medicinal chemistry due to its unique structural features and broad applicability. Its role in developing kinase inhibitors and neurodegenerative disease treatments underscores its significance in addressing critical health challenges. As research continues to uncover new synthetic methodologies and pharmacological applications,3-Chloroadamantane-1-carboxylic acid is poised to remain at the forefront of drug discovery efforts.

• 35207-71-7(3-chlorocyclobutane-1-carboxylic acid)
• 18341-71-4(Bicyclo[2.2.0]hexane-1-carboxylicacid, 4-chloro-)
• 72764-18-2(Bicyclo[2.2.2]octane-1-carboxylic acid, 3-chloro-)
• 35207-70-6(trans-3-chlorocyclobutane-1-carboxylic acid)
• 35207-69-3(cis-3-Chlorocyclobutanecarboxylic acid)
• 67990-01-6(5-Chloro-2-methylcyclohexanecarboxylic acid)
• 67990-02-7(4-chloro-2-methylcyclohexanecarboxylic acid)
• 116468-85-0(Cyclohexaneacetic acid, 1-chloro-4-(1,1-dimethylethyl)-, cis-)
• 500997-57-9(Bicyclo[2.2.2]octane-1-carboxylic acid, 4-(chloromethyl)-)
• 1007-73-4(c9h13clo2)